This post is sponsored by DIA.
Patients participating in clinical trials did not previously have an easy way to receive or use the clinical data generated during a trial to improve their personal health and wellness. That is changing thanks to initiatives like The Blue Button Project, which will be highlighted at the DIA 2014 50th Annual Meeting.
This year’s Annual Meeting, in San Diego from June 15 to 19, will feature a session titled “Enabling Participants’ Access to the Electronic Clinical Trial Data: The Blue Button Project” under the Processes and Technologies for Clinical Research track.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
The session, to be held on June 17 from 1:30-3:00 PM, will focus on the Blue Button Project, which a large pharmaceutical company launched in December 2013 to allow patients who participated in specified clinical trials the opportunity to download their individual clinical data.
Using the Blue Button standard that the White House launched, patients are empowered to use their individual electronic clinical data to improve their overall health and wellness, from sharing data with health care providers to powering clinical risk assessment tools.
Speakers will discuss key challenges and solutions for implementation to help enable other research sponsors to share data with their trial participants, and discuss the expected evolution and the pathway for two-way data sharing with research participants to transform the conduct of clinical trials.
Craig H. Lipset, Head of Clinical Innovation, Worldwide Research and Development at Pfizer Inc., will chair the session. Patient Activist and Mural Artist Regina Holliday will provide the patient’s perspective. Additional speakers have been confirmed.
The DIA 2014 50th Annual Meeting: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.
This year’s event celebrates DIA’s 50th Anniversary and will feature 260+ educational offerings over 21 tracks, 450+ exhibiting companies, more than 125 representatives from global regulatory agencies, and much more. The meeting provides participants with a valuable opportunity to network with professionals from around the world, share knowledge and build new relationships.
Find out more about DIA 2014 50th Annual Meeting at http://www.diahome.org/DIA2014.
